spacer
home > ict > winter 2019 > animal models to study infectious pathogens
PUBLICATIONS
International Clinical Trials

Animal Models to Study Infectious Pathogens

Until recently, several issues prevented the use of cotton rats (Sigmodon hispidus) as an experimental model on a widespread level. They lacked inbreeding, they were not readily commercially available, and reagents specific to this species had yet to be developed. Additionally, cotton rats are notoriously hard models to work with. Although cotton rats are not normally aggressive, they dislike being handled, can move very rapidly, and jump well. Significant advances have now been made to alleviate these issues. A variety of immunological methods have been established for the cotton rat so that immunological responses after infection or vaccination can be evaluated. Also, a wide variety of chemokine and cytokine genes have been cloned and enzyme-linked immunosorbent assay and other antibody-based systems are readily available. Some strategies can overcome the challenges of working with cotton rats, and their necessity to vaccine development ultimately makes them more than worth the trouble.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Carmen Sweeney PhD is the Scientific Director of in vivo/ex vivo testing services at Charles River’s site, Ballina, Ireland. Carmen has over 20 years’ experience in the industry, having held a number of positions at Charles River, from Study Director, Manager of Methods Development, to her current role. Carmen received her PhD in biological and biomedical sciences and toxicology MSc from the University of Ulster, UK.
spacer
Carmen Sweeney PhD
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera acquires Insight Product Development to strengthen its capabilities

“Every day at Nemera, we work to improve the lives of millions of patients worldwide by designing, developing and manufacturing innovative drug delivery devices. Our vision as a team is to become the most patient-centric drug delivery device company in the industry. We partner closely with our customers to deliver innovative and high quality devices, to ensure that patients will receive the best product and service possible” Marc Hämel, CEO
More info >>

White Papers
 
Industry Events

Evolution Summit

20-22 July 2020, The Ritz Carlton, Fort Lauderdale, FL

The 22nd Evolution Summit is the premium forum bringing leading drug development executives and solution providers together. As an invitation-only event, taking place behind closed doors, the Summit offers an intimate environment for a focused discussion of key new drivers shaping drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement